BCYC Competitors & Alternatives
Compare Bicycle Therapeutics Ltd with similar stocks in the same industry
Biotechnology
BCYC
Main Stock$3.87
Tradestie Score
40
Market Cap
$577.32M
Revenue Growth
-0.8%
Analyst Upside
+154.7%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.07
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$19.15
|
$297.23M | - | 52 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$27.92
|
$293.03M | - | 51 | Compare |
|
OMER
Omeros Corporation
|
$12.56
|
$281.75M | 10.4 | 56 | Compare |
|
DBVT
DBV Technologies S.A.
|
$13.58
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$1.84
|
$275.13M | - | 50 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$21.41
|
$269.08M | - | 55 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.52
|
$262.67M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$32.87
|
$256.54M | - | 55 | Compare |
More BCYC Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
229 stocks in this industry